pI: 5.8586 |
Length (AA): 272 |
MW (Da): 29356 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
101 | 269 | 2b0r (A) | 39 | 198 | 31.00 | 0 | 1 | 0.94 | -0.7 |
105 | 264 | 1f5i (A) | 369 | 521 | 31.00 | 0 | 1 | 1.04 | -0.88 |
122 | 253 | 2b0r (A) | 41 | 185 | 38.00 | 0 | 1 | 0.92 | -1.01 |
2 | 31 | 2kpy (A) | 62 | 100 | 57.00 | 0.12 | 0.53 | 0.557294 | -1.31 |
104 | 271 | 1k8f (A) | 319 | 473 | 37.00 | 0 | 1 | 1.08465 | -0.84 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127770)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G34490 | cyclase associated protein 1 |
Babesia bovis | BBOV_I003280 | conserved hypothetical protein |
Brugia malayi | Bm1_01905 | CAP protein |
Candida albicans | CaO19.8135 | adenylate cyclase-associated protein involved in regulation of cyclic AMP levels and filamentous growth |
Candida albicans | CaO19.505 | adenylate cyclase-associated protein involved in regulation of cyclic AMP levels and filamentous growth |
Caenorhabditis elegans | CELE_F41G4.2 | Protein CAS-1, isoform B |
Cryptosporidium hominis | Chro.50350 | LD24380p |
Cryptosporidium parvum | cgd5_440 | protein with 2 CAP (CARP) domains, possible adenyl cyclase-associated protein |
Dictyostelium discoideum | DDB_G0288769 | cyclase associated protein |
Drosophila melanogaster | Dmel_CG33979 | capulet |
Echinococcus granulosus | EgrG_000897100 | adenylyl cyclase associated protein 1 |
Entamoeba histolytica | EHI_136150 | adenylyl cyclase-associated protein, putative |
Entamoeba histolytica | EHI_081430 | adenylylcyclase-associated protein, putative |
Echinococcus multilocularis | EmuJ_000897100 | adenylyl cyclase associated protein 1 |
Homo sapiens | ENSG00000112186 | CAP, adenylate cyclase-associated protein, 2 (yeast) |
Homo sapiens | ENSG00000131236 | CAP, adenylate cyclase-associated protein 1 (yeast) |
Leishmania braziliensis | LbrM.35.5860 | G-actin binding protein, putative,CAP/Srv2p, putative |
Leishmania donovani | LdBPK_365830.1 | adenylyl cyclase-associated protein, putative |
Leishmania infantum | LinJ.36.5830 | G-actin binding protein, putative,CAP/Srv2p, putative |
Leishmania major | LmjF.36.5590 | G-actin binding protein, putative,CAP/Srv2p, putative |
Loa Loa (eye worm) | LOAG_15179 | hypothetical protein |
Loa Loa (eye worm) | LOAG_07646 | hypothetical protein |
Mus musculus | ENSMUSG00000028656 | CAP, adenylate cyclase-associated protein 1 (yeast) |
Mus musculus | ENSMUSG00000021373 | CAP, adenylate cyclase-associated protein, 2 (yeast) |
Neospora caninum | NCLIV_054140 | adenylyl cyclase associated protein, putative |
Oryza sativa | 4345716 | Os08g0447900 |
Oryza sativa | 4333945 | Os03g0722600 |
Plasmodium berghei | PBANKA_0208000 | cyclase-associated protein |
Plasmodium falciparum | PF3D7_0105300 | cyclase-associated protein |
Plasmodium knowlesi | PKNH_0208400 | cyclase-associated protein, putative |
Plasmodium vivax | PVX_081498 | hypothetical protein, conserved |
Plasmodium vivax | PVX_081502 | hypothetical protein, conserved |
Saccharomyces cerevisiae | YNL138W | Srv2p |
Schistosoma japonicum | Sjp_0203560 | Adenylyl cyclase-associated protein 1, putative |
Schistosoma mansoni | Smp_014010 | adenylyl cyclase-associated protein |
Schmidtea mediterranea | mk4.007218.01 | Adenylyl cyclase-associated protein |
Schmidtea mediterranea | mk4.015808.00 | Adenylyl cyclase-associated protein |
Trypanosoma brucei gambiense | Tbg972.10.11320 | G-actin binding protein, putative,CAP/Srv2p, putative |
Trypanosoma brucei | Tb927.10.9250 | adenylyl cyclase-associated protein, putative |
Trypanosoma congolense | TcIL3000_10_8020 | adenylyl cyclase-associated protein, putative |
Trypanosoma cruzi | TcCLB.509799.30 | adenylyl cyclase-associated protein, putative |
Trypanosoma cruzi | TcCLB.504137.80 | adenylyl cyclase-associated protein, putative |
Toxoplasma gondii | TGME49_310030 | cyclase-associated protein, putative |
Theileria parva | TP03_0176 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_407250 | adenylyl cyclase-associated protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.9250 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.9250 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.9250 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.9250 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
YNL138W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_310030 | Toxoplasma gondii | Probably non-essential | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.